Adoption Trend of Climate-Resilient Rice Varieties in Bangladesh

Rice is a major crop in Bangladesh that supports both food security and livelihoods. However, a need remains for improved productivity and adaptation to the risks associated with climate change. To accomplish this, the increased adoption of climate-resilient and high-yielding rice varieties can be beneficial. Therefore, we conducted a study in Bangladesh over three consecutive years: 2016, 2017, and 2018. The scope of the study included the major cropping season (wet), Aman. The yield advantages of climate-resilient rice varieties were evaluated and compared with those of the varieties popular with farmers. We included new stress-tolerant varieties, such as submergencetolerant rice (BRRI dhan51 and BRRI dhan52) and drought-tolerant rice (BRRI dhan56 and BRRI dhan71), along with farmer-chosen controls, in the study. We conducted the evaluation through on-farm trials to compare the varieties in both submergence- and drought-affected environments. The seasonal trials provided measured results of yield advantages. The participating farmers were also studied over the three-year-period to capture their varietal adoption rates. We calculated both the location estimated yield advantages (LEYA) and the location observed yield advantages (LOYA). The results revealed that, under non-stress conditions, the grain yields of climate-resilient varieties were either statistically similar to or higher than those of the farmer-chosen controls. Our study also revealed a year-to-year progressive adoption rate for the introduced varieties. The study suggests that the widescale introduction and popularization of climate-resilient varieties can ensure higher productivity and climate risk adaptation. The close similarity between LOYA and LEYA indicated that the observational and experiential conclusions of the host farmers were similar to the scientific performance of the varieties. We also found that comparison performed through on-farm trials was a critical method for enhancing experiential learning and obtaining an accurate estimation of yield advantages

CMS physics technical design report : Addendum on high density QCD with heavy ions

Peer reviewe

Oral flecainide is effective in management of refractory tachycardia in infants

Background: Propranolol and digoxin have been used as first line drugs for treatment of supraventricular tachycardia (SVT) in infants. Flecainide and other drugs have been effective as a second line treatment for controlling refractory SVT. Material and methods: This is a prospective study without randomization and control. The inclusion criteria were: infants (≤12 months) with tachyarrhythmia who failed to respond to first line drugs. Patients having post-surgical arrhythmias were excluded from the study. Results: A total of 8 infants were treated with flecainide for refractory tachyarrhythmia's. Diagnosis on electrocardiogram (ECG) was atrioventricular reentry tachycardia (AVRT) in 5, atrial ectopic tachycardia (AET) in 2, a combination of AVRT and atrioventricular nodal reentry tachycardia (AVNRT) in 1. All patients had failed trial of antiarrhythmic drugs prior to presentation: digoxin and propranolol in 7, amiodarone in 3, cardioversion in 1. Flecainide (80–130 mg/m2 orally) resulted in termination of the tachycardia in all 8 patients. Acute pharmacological termination of arrhythmia occurred with oral flecainide loading in 1 and temporarily with intravenous esmolol loading in 1 patient. Adjuvant therapy in form of propranolol was used in 5 and digoxin in 2. There were no side effects noted. Four episodes of recurrence were noted in 3 patients over 2 years, all of which responded to dose increase. Mean follow up time is 24.75 months. Conclusion: This small case series indicates that flecainide is an effective antiarrhythmic agent, free of side effects and when used orally is capable of terminating and controlling relatively resistant supraventricular tachycardia in children

Glenard's disease

Through this teaching image of gastroptosis in a 21 year old girl, we reiterate that Glenard's disease should be revisited since there are only very few reports in the existing literature

Controlled Ventilation Enhances Catheter Stability During Radiofrequency Ablation

Variations in the amplitude of the atrial and ventricular depolarization waves of the intracardiac electrogram occur during different phases of respiration. Therefore, we tested whether controlled ventilation would reduce ablation attempts and increase the rate of success in patients undergoing radiofrequency ablation with general anesthesia. Thirty‐eight children were divided into two groups: (1) controlled and (2) noncontrolled or cyclic ventilation. In the controlled ventilation group, the mapping electrogram was recorded during sustained inspiration, sustained expiration, and cyclic ventilation. Ablation was done in the phase of ventilation that had the least variability in atrial and ventricular amplitudes. Seventeen patients in the controlled ventilation group had tracings adequate for review. In eight patients, ablation was done during sustained inspiration with the percentage change of atrial and ventricular amplitudes (15%± 16% and 13%± 16%, respectively) being < that during sustained expiration (38%± 27%, P = 0.04 and 20%± 21 %) or during cyclic ventilation (57%± 27%, P < 0.01 and 54%± 26%, P = 0.003). In nine patients, ablation was done during sustained expiration with the percentage change of atrial and ventricular amplitudes (5%± 5% and 5%± 2%) being less than that during sustained inspiration (21%± 14%, P = 0.01 and 11%± 6%, P = 0.01) or during cyclic ventilation (68%± 23%, P < 0.001 and 48 ± 26%, P = 0.001). We achieved success with each patient in both groups, but the number of ablation attempts were less in the controlled ventilation group 1 (3 ± 2), as compared to the cyclic ventilation group 2 (8 ± 8; P < 0.02). We concluded that controlled ventilation reduced the number of ablation attempts and facilitated the ablation procedure